Prothena
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Prothena and other ETFs, options, and stocks.About PRTA
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases.
CEOGene G. Kinney
CEOGene G. Kinney
Employees163
Employees163
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2012
Founded2012
Employees163
Employees163
PRTA Key Statistics
Market cap348.80M
Market cap348.80M
Price-Earnings ratio-3.15
Price-Earnings ratio-3.15
Dividend yield—
Dividend yield—
Average volume1.36M
Average volume1.36M
High today$6.59
High today$6.59
Low today$6.39
Low today$6.39
Open price$6.45
Open price$6.45
Volume281.46K
Volume281.46K
52 Week high$25.42
52 Week high$25.42
52 Week low$6.39
52 Week low$6.39
PRTA News
Simply Wall St 1d
Why Investors Shouldn't Be Surprised By Prothena Corporation plc's 27% Share Price PlungeUnfortunately for some shareholders, the Prothena Corporation plc ( ) share price has dived 27% in the last thirty days, prolonging recent pain. The recent drop...
TipRanks 7d
Prothena Shareholders Approve Key Amendments at AGMConfident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive underval...
Analyst ratings
80%
of 10 ratingsBuy
80%
Hold
20%
Sell
0%
People also own
Based on the portfolios of people who own PRTA. This list is generated using Robinhood data, and it’s not a recommendation.